Skip to main content
. 2023 Nov 2;12(21):6898. doi: 10.3390/jcm12216898

Table 2.

Differential diagnoses of pulmonary sarcoidosis, related to site of thoracic involvement.

Site of Thoracic Involvement Infectious Granulomatous Diseases Non-Infectious Granulomatous Diseases
Lung parenchyma Tuberculosis Hypersensitivity pneumonitis (many causal antigens)
NTM infections Chemical induced granulomatosis (e.g., beryllium, aluminum, zirconium, silica, and talc)
Histoplasmosis (very rare in Europe) Drug-induced granulomatosis (e.g., TNF-alpha antagonists, immune checkpoint inhibitors, targeted therapies, and interferons)
Parasitic infections (very rare, e.g., leishmaniosis, paragonimiasis, and schistosomiasis), occurring mainly in endemic countries Aspiration pneumonia with foreign body granulomatosis
Viral infections (very rare, e.g., varicella zoster and cytomegalovirus), mainly in immunocompromised patients) Vasculitis, CTD, and inflammatory disease (e.g., GPA, EGPA, NSG, ILD in Sjogren’s syndrome, and Crohn’s disease)
Other infections (very rare, e.g., Whipple’s disease, cryptococcosis, coccidioidomycosis, and mucormycosis), mainly in immunocompromised patients Immune deficiency granulomatosis (e.g., granulomatous-associated CVID and CGD)
Genetic disorders: Blau syndrome
Malignancy-associated granulomatosis (e.g., cancer and lymphoma)
Other proliferative disorders (e.g., LCH, ECD, and lymphomatoid granulomatosis)
Thoracic lymph nodes Tuberculosis Sarcoid-like reaction (especially occurring in linkage to malignancies but also in rare occasions of hypersensitivity pneumonitis and CTD such as Sjogren’s syndrome)
NTM infections Chemical-induced granulomatosis (e.g., beryllium, aluminum, zirconium, silica, and talc)
Histoplasmosis (very rare in Europe) Drug-induced granulomatosis (e.g., TNF-alpha antagonists, immune checkpoint inhibitors, targeted therapies, and interferons)
Other infections (very rare, e.g., Whipple’s disease and fungal infections) Immune deficiency granulomatosis (e.g., granulomatous-associated CVID and CGD)
Malignancy-associated granulomatosis (e.g., cancer and lymphoma)

Definition of abbreviations: CGD, chronic granulomatous disease; CTD, connective tissue disease; CVID, common variable immune deficiency; ECD, Erdheim–Chester disease; EGPA, eosinophilic granulomatosis with polyangiitis; GPA, granulomatosis with polyangiitis; ILD, interstitial lung disease; LCH, Langerhans cell histiocytosis; NSG, necrotizing sarcoid granulomatosis; NTM, nontuberculous mycobacteria; TNF, tumor necrosis factor. The differential diagnosis should be prioritized on the basis of the individual’s clinical history and presentation and can depend on geographic location.